Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Diagnosis and Risk Prediction of Dilated Cardiomyopathy in the Era of Big Data and Genomics

26 Feb 2021

Abstract excerpt

Dilated cardiomyopathy (DCM) is a leading cause of heart failure and life-threatening ventricular arrhythmias (LTVA). Work-up and risk stratification of DCM is clinically challenging, as there is great heterogeneity in phenotype and genotype. Throughout the last decade, improved genetic testing of patients has identified genotype-phenotype associations and enhanced evaluation of at-risk relatives leading to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cardiomyopathy and Myosin Studies
Share to Cardiovascular Effects of Exercise
Share to Cardiovascular Function and Risk Factors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33652931
DOI: 10.3390/jcm10050921

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Diagnosis and Risk Prediction of Dilated Cardiomyopathy in the Era of Big Data and GenomicsPMID 33652931Read ↗

Phenotypic clustering of dilated cardiomyopathy patients highlights important pathophysiological differences.Semantic proximity Read ↗

The Frequency, Penetrance and Variable Expressivity of Dilated Cardiomyopathy-Associated Putative Pathogenic Gene Variants in UK Biobank ParticipantsSemantic proximity Read ↗

Where genome meets phenome: rationale for integrating genetic and protein biomarkers in the diagnosis and management of dilated cardiomyopathy and heart failure.Semantic proximity Read ↗

Frequency, Penetrance, and Variable Expressivity of Dilated Cardiomyopathy–Associated Putative Pathogenic Gene Variants in UK Biobank ParticipantsSemantic proximity Read ↗

Characterization of the genetic architecture of dilated cardiomyopathy using families and cohortsSemantic proximity Read ↗

The application of big data to cardiovascular disease: paths to precision medicine.Semantic proximity Read ↗

Integrated genomic analysis defines molecular subgroups in dilated cardiomyopathy and identifies novel biomarkers based on machine learning methodsSemantic proximity Read ↗

Utility of polygenic risk scores in diagnostic genetic testing for dilated cardiomyopathySemantic proximity Read ↗

Familial Dilated Cardiomyopathy.Semantic proximity Read ↗

Identification of potential biomarkers associated with dilated cardiomyopathy by bioinformatics analysisSemantic proximity Read ↗

An Updated Evidence Assessment of the Genetic Causes of Dilated CardiomyopathySemantic proximity Read ↗

Rationale and Design of an Artificial Intelligence Model for Diastolic Heart Failure (AID-HF): A Canadian Cardiomyopathy Collaborative (C3) StudySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.